lagoda investment management, l.p.

3 columbus circle, suite 2215
new york, new york 10019

NYS Entity Status
ACTIVE

NYS Filing Date
APRIL 10, 2014

NYS DOS ID#
4560051

County
NEW YORK

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED PARTNERSHIP

Name History
2014 - LAGODA INVESTMENT MANAGEMENT, L.P.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • New York advances drone industry with testing corridor
    By MARY ESCH, Associated Press - Sunday Oct 22, 2017

    ROME, N.Y. (AP) — Envisioning a day when millions of drones will buzz around delivering packages, watching crops or inspecting pipelines, a coalition is creating an airspace corridor in upstate New York where traffic management systems will be developed and unmanned aircraft can undergo safety and performance testing.The unmanned aircraft traffic management corridor, jump-started by a $30 million state investment, will extend 50 miles (80 kilometers) west over mostly rural farmland from Griffiss International Airport, a former Air Force base in Rome that is already home to NASA-affiliated drone testing.It will be equipped with radar and ground-based sensors to enable what Democratic Gov.

    Source: SFGATE.com: Tech News
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Why Nelson Peltz Wants P.&G. to See Him as a ‘Constructivist’
    By ANDREW ROSS SORKIN - Tuesday Jul 18, 2017

    The financier, who dislikes the term “activist,” has made his name by investing in companies using a friendlier approach. But he’s still an activist.

    Source: NYT > Home Page
  • George Soros’ investment firm sheds employees
    By Kevin Dugan - Thursday Oct 26, 2017

    Nine people, including two portfolio managers, left George Soros’ massive $26 billion investment office this week, The Post has learned. One manager exited to start his own fund with money seeded from Soros, sources told The Post. The other left after posting lackluster returns, the sources said. Seven others, said to be back-office workers, were...

    Source: New York Post: Business
  • Martin Shkreli is found guilty of fraud
    By Stephanie Clifford and Colin Moynihan - Friday Aug 4, 2017

    NEW YORK — Martin Shkreli, accused of defrauding his hedge fund investors and a pharmaceutical company, was convicted on three of eight counts on Friday, after a five-week trial in U.S. District Court in Brooklyn, N.Y.Shkreli was accused of securities and wire fraud related to two hedge funds he ran, MSMB Capital and MSMB Healthcare.The prosecution brought forth an “avalanche” of evidence, as prosecutor Jacquelyn Kasulis put it in her rebuttal argument, that included a threatening letter he sent to the wife of a former employee, statements he sent to MSMB investors showing great returns at the same time he had no money in fund accounts, three versions of a backdated agreement to make it look as if MSMB Capital had invested in Retrophin when it had not, as well as claims about assets under management that were wildly out of line with his actual fund size.

    Source: SFGATE.com: Business and Technology News